Vertex Pharmaceuticals, Inc. (VRTX)
459.78
-3.12
(-0.67%)
USD |
NASDAQ |
Dec 29, 16:00
461.20
+1.42
(+0.31%)
After-Hours: 20:00
Vertex Pharmaceuticals Research and Development Expense (Quarterly): 977.70M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Amgen, Inc. | 1.90B |
| Eli Lilly & Co. | 3.466B |
| IDEXX Laboratories, Inc. | 63.42M |
| Regeneron Pharmaceuticals, Inc. | 1.338B |